5-71458581-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018429.3(BDP1):c.215C>T(p.Thr72Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000255 in 1,605,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018429.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BDP1 | ENST00000358731.9 | c.215C>T | p.Thr72Ile | missense_variant, splice_region_variant | 2/39 | 1 | NM_018429.3 | ENSP00000351575.4 | ||
BDP1 | ENST00000508917.6 | n.407C>T | splice_region_variant, non_coding_transcript_exon_variant | 2/32 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151882Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000821 AC: 2AN: 243728Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132238
GnomAD4 exome AF: 0.0000268 AC: 39AN: 1453370Hom.: 0 Cov.: 31 AF XY: 0.0000277 AC XY: 20AN XY: 722970
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151882Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74168
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.215C>T (p.T72I) alteration is located in exon 2 (coding exon 2) of the BDP1 gene. This alteration results from a C to T substitution at nucleotide position 215, causing the threonine (T) at amino acid position 72 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at